94 related articles for article (PubMed ID: 7681745)
1. Expression of hepatitis C virus core protein as a fusion protein with maltose binding protein. Detection of anti-hepatitis C core antibody by western blot.
Yokosuka O; Ito Y; Sakuma J; Imazeki F; Ohto M; Omata M
Dig Dis Sci; 1993 Apr; 38(4):626-30. PubMed ID: 7681745
[TBL] [Abstract][Full Text] [Related]
2. Expression of HCV E2/NS1 protein as a fusion protein with maltose binding protein: detection of anti-E2/NS1 antibody in chronic liver disease.
Yokosuka O; Omata M; Ito Y; Ohto M
Gut; 1993; 34(2 Suppl):S64-5. PubMed ID: 7686121
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus core protein: synthesis, affinity purification and immunoreactivity with infected human sera.
Khanna A; Ray R
Gene; 1995 Feb; 153(2):185-9. PubMed ID: 7533115
[TBL] [Abstract][Full Text] [Related]
4. Early detection of anti-HCc antibody in acute hepatitis C virus (HCV) by western blot (immunoblot) using a recombinant HCV core protein fragment.
Yeh CT; Han CM; Lo SY; Ou JH; Fan KD; Sheen IS; Chu CM; Liaw YF
J Clin Microbiol; 1994 Sep; 32(9):2235-41. PubMed ID: 7529251
[TBL] [Abstract][Full Text] [Related]
5. Correlation of serum antibody titers against hepatitis C virus core protein with clinical features by western blot (immunoblot) analysis using a recombinant vaccinia virus expression system.
Nishizono A; Hiraga M; Mifune K; Terao H; Fujioka T; Nasu M; Goto T; Misumi J; Moriyama M; Arakawa Y
J Clin Microbiol; 1993 May; 31(5):1173-8. PubMed ID: 7684748
[TBL] [Abstract][Full Text] [Related]
6. Expression of MBP-HCV NS1/E2 fusion protein in E. coli and detection of anti-NS1/E2 antibody in type C chronic liver disease.
Mita E; Hayashi N; Ueda K; Kasahara A; Fusamoto H; Takamizawa A; Matsubara K; Okayama H; Kamada T
Biochem Biophys Res Commun; 1992 Mar; 183(3):925-30. PubMed ID: 1314578
[TBL] [Abstract][Full Text] [Related]
7. Detection of antibody to hepatitis C E2/NS1 protein in patients with type C hepatitis.
Yokosuka O; Ito Y; Imazeki F; Ohto M; Omata M
Biochem Biophys Res Commun; 1992 Nov; 189(1):565-71. PubMed ID: 1280430
[TBL] [Abstract][Full Text] [Related]
8. Expression of the full-length HCV core subgenome from HCV gentoype-1a and genotype-3a and evaluation of the antigenicity of translational products.
Ansari MA; Irshad M; Agarwal SK; Chosdol K
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):806-13. PubMed ID: 23442416
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of antibodies to hepatitis C virus during interferon-alpha therapy.
Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
Hepatology; 1993 Jun; 17(6):960-5. PubMed ID: 7685734
[TBL] [Abstract][Full Text] [Related]
10. HCV RNA and antibody to HCV core protein in Japanese patients with chronic liver disease.
Yuki N; Hayashi N; Hagiwara H; Takehara T; Kasahara A; Fusamoto H; Manabe S; Takamizawa A; Kamada T; Okayama H
Dig Dis Sci; 1992 Oct; 37(10):1483-8. PubMed ID: 1327684
[TBL] [Abstract][Full Text] [Related]
11. A hepatitis C virus core polypeptide expressed in chloroplasts detects anti-core antibodies in infected human sera.
Madesis P; Osathanunkul M; Georgopoulou U; Gisby MF; Mudd EA; Nianiou I; Tsitoura P; Mavromara P; Tsaftaris A; Day A
J Biotechnol; 2010 Feb; 145(4):377-86. PubMed ID: 19969031
[TBL] [Abstract][Full Text] [Related]
12. Association of hepatitis C virus carrier state with the occurrence of hepatitis C virus core antibodies.
Claeys H; Volckaerts A; De Beenhouwer H; Vermylen C
J Med Virol; 1992 Apr; 36(4):259-64. PubMed ID: 1315838
[TBL] [Abstract][Full Text] [Related]
13. Anti-C100-3 antibody status, viral genomic sequences, and clinical features in chronic hepatitic patients with hepatitis C virus RNA in sera.
Morii K; Shimomura H; Nakagawa H; Hasui T; Tsuji T
Acta Med Okayama; 1992 Aug; 46(4):285-93. PubMed ID: 1332424
[TBL] [Abstract][Full Text] [Related]
14. Detection of hepatitis C virus infection by enzyme-linked immunosorbent assay system using core protein expressed in Escherichia coli.
Muraiso K; Hijikata M; Kato N; Shimotohno K; Okazaki N; Ohkoshi S; Uura M; Kaneko S; Kobayashi K; Omata M
Jpn J Cancer Res; 1991 Aug; 82(8):879-82. PubMed ID: 1716622
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus infection in children with hemophilia: characterization of antibody response to four different antigens and relationship of antibody response, viremia, and hepatic dysfunction.
Kanesaki T; Kinoshita S; Tsujino G; Yoshioka K; Ikegami N
J Pediatr; 1993 Sep; 123(3):381-7. PubMed ID: 7689096
[TBL] [Abstract][Full Text] [Related]
16. High detection rate of hepatitis C virus E2 antibody in patients with type C hepatitis.
Yokosuka O; Ito Y; Ohto M; Omata M
Gastroenterol Jpn; 1993 May; 28 Suppl 5():52-4. PubMed ID: 7689507
[TBL] [Abstract][Full Text] [Related]
17. Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy.
Park YM; Byun BH; Choi JY; Bae SH; Kim BS; So HS; Ryu WS
J Korean Med Sci; 1999 Apr; 14(2):165-70. PubMed ID: 10331562
[TBL] [Abstract][Full Text] [Related]
18. Serodiagnosis of hepatitis C virus infection by ELISA for antibodies against the putative core protein (p20c) expressed in Escherichia coli.
Yoshikawa A; Takahashi K; Kishimoto S; Tsuda F; Akahane Y; Naito S; Tanaka T; Yoshizawa H; Yamasaki M; Okamoto H
J Immunol Methods; 1992 Apr; 148(1-2):143-50. PubMed ID: 1373423
[TBL] [Abstract][Full Text] [Related]
19. [Enzyme-linked immunosorbent assay for antibodies against core protein of hepatitis C virus with a synthetic oligopeptide].
Sugiyasu T
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):148-58. PubMed ID: 7686127
[TBL] [Abstract][Full Text] [Related]
20. Distinguishing acute from symptomatic chronic hepatitis C virus (HCV) infection by site-directed serology of the HCV structural proteins.
Zhang ZX; Chen M; Sönnerborg A; Weiland O; Sällberg M
J Infect Dis; 1995 May; 171(5):1356-9. PubMed ID: 7538552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
